Paratek Pharmaceuticals, Inc. (PRTK) Social Stream



Paratek Pharmaceuticals, Inc. (PRTK): $2.23

0.04 (+1.83%)

POWR Rating

Component Grades

Momentum

C

Stability

F

Sentiment

Quality

B

Add PRTK to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#48 of 382

in industry

PARATEK PHARMACEUTICALS INC (PRTK) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering PRTK.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $27 $10 $17.333 $2.19 691.46%
2022-02-10 3 $27 $11 $17.666 $2.19 706.67%
2022-03-14 3 $27 $11 $17 $2.19 676.26%
2022-03-17 3 $22 $11 $15.333 $2.19 600.14%
2022-05-04 3 $30 $11 $19 $2.19 767.58%
2022-08-08 3 $30 $11 $18.5 $2.19 744.75%
2022-11-04 3 $30 $11 $18 $2.19 721.92%
2023-01-24 2 $30 $9 $19.666 $2.19 797.99%
2023-03-16 2 $30 $7 $19 $2.19 767.58%
2023-03-20 2 $30 $7 $15.666 $2.19 615.34%
2023-04-17 3 $24 $7 $13.666 $2.19 524.02%
2023-05-10 3 $24 $5 $13 $2.19 493.61%
2023-05-11 3 $24 $5 $11.666 $2.19 432.69%
2023-08-07 3 $24 $2.15 $9.433 $2.19 330.73%

The Trend in the Analyst Price Target


Over the past 15 months, PRTK's average price target has gone down $9.07.

Over the past 39 weeks, PRTK's average upside potential has been 669.38%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-24 1 30 9 19.666 2.09 840.96%
2023-03-20 2 10 7 8.500 1.37 520.44%
2023-03-20 2 30 7 15.666 1.37 1043.5%
2023-05-10 3 24 5 13.000 1.87 595.19%
2023-05-11 3 24 5 11.666 1.82 540.99%

PRTK Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.33 1 0 2 0 0 3

The Trend in the Broker Recommendations


PRTK's average broker recommendation rating worsened by 1.33 over the prior 122 days.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for PRTK as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, PARATEK PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is higher than 2073.07% of them.
  • In the context of all US stocks, PARATEK PHARMACEUTICALS INC's number of analysts covering the stock is higher than 134.6% of them.
  • PARATEK PHARMACEUTICALS INC's variance in analysts' estimates is lower than -1765.45% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, PARATEK PHARMACEUTICALS INC's average analyst price target is greater than 630.8% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PARATEK PHARMACEUTICALS INC are VBIV, ATNF, and GTHX.

Is PRTK a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!